Debbie Orcutt
patientFemale0.0Global Dominance: 0.00%
Debbie Orcutt, diagnosed with aggressive pancreatic cancer in 2024, participated in a clinical trial for an experimental drug, daraxonrasib, after being given limited treatment options. Her tumors shrank by 64%, raising hopes for innovative cancer therapies.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Debbie Orcutt was diagnosed with pancreatic cancer and decided to participate in a clinical trial for an experimental drug.
Πειραματικό χάπι γεννά ελπίδες για έναν από τους πιο θανατηφόρους καρκίνουςKathimerini·
Greece· 2025-11-06
Greece· 2025-11-06
